Investors

Press Releases

 
Press Releases
  Date Title View
Jun 23, 2011
Watertown, MA – June 23, 2011 – Tetraphase Pharmaceuticals, Inc., a clinical-stage life science company developing a portfolio of potent new antibiotics designed to be effective against dangerous, drug-resistant bacteria, including multidrug-resistant (MDR) gram-negative pathogens, today announced that the company will ...
May 9, 2011
Watertown, MA - May 9, 2011 - Tetraphase Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on next-generation antibiotics, announced today that it is presenting new results of several studies designed to support the continued advancement of its lead antibiotic, TP-434, a potent new broad-spectrum intravenous...
Apr 6, 2011
Watertown, MA – April 6, 2011 – Tetraphase Pharmaceuticals, Inc., a clinical-stage life science company developing a portfolio of potent new antibiotics designed to be effective against dangerous, drug-resistant bacteria, including multidrug-resistant (MDR) gram-negative pathogens, today announced that the Company will ...
Mar 30, 2011
Watertown, MA – March 30, 2011 – Tetraphase Pharmaceuticals, Inc., a clinical-stage life science company developing a portfolio of potent new antibiotics designed to be effective against dangerous, drug-resistant bacteria, including multidrug-resistant (MDR) gram-negative pathogens, today announced that the Company will...
Mar 3, 2011
Watertown, MA – March 3, 2011 – Tetraphase Pharmaceuticals, Inc., a clinical-stage life science company developing a portfolio of potent new antibiotics designed to be effective against dangerous, drug-resistant bacteria (including multidrug-resistant (MDR) gram-negative pathogens) today announced that the Company will ...
Feb 10, 2011
Watertown, MA – February 10, 2011 – Tetraphase Pharmaceuticals, Inc., a clinical-stage life science company with a groundbreaking synthetic chemistry technology platform that has the power to deliver solutions to the global health crisis caused by antibiotic resistance, today announced that the Company will participate ...
Jan 24, 2011
Watertown, MA – January 24, 2011 – Tetraphase Pharmaceuticals, a clinical-stage life science company with a groundbreaking synthetic chemistry technology platform that has the power to deliver solutions to the global health crisis caused by antibiotic resistance, announced today that it has appointed Patrick Horn, M.D.,...
Nov 11, 2010
Watertown, MA – November 11, 2010 – Tetraphase Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing a portfolio of potent, novel and differentiated antibiotics designed to be effective against drug resistant bacteria, including multidrug-resistant (MDR) Gram-negative pathogens, today announced th...
Oct 12, 2010
Watertown, MA – October 12, 2010 – Tetraphase Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing a portfolio of potent, novel and differentiated antibiotics designed to be effective against drug resistant bacteria, including multidrug-resistant (MDR) ...
Oct 1, 2010
Watertown, MA – October 1, 2010 –Tetraphase Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing a portfolio of potent, novel and differentiated antibiotics designed to be effective against drug resistant bacteria, including multidrug-resistant (MDR) Gram-negative pathogens, today announced that ...
FirstPrevious
...
14
NextLast
= add release to Briefcase